NPM1 and acute myeloid leukemia: As for the usefulness of WT1 monitoring as an MRD marker in genetic variant cases, we investigated a case of NPM1-mutated AML enrolled in the present study with regard to the usefulness of WT1 monitoring as an MRD marker instead of the measurement of the NPM1 levels.